New Caledonia vs Saint Helena: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
New Caledonia
2.3%
in 2024
Saint Helena
2.0%
in 2024
New Caledonia rank
12th
Saint Helena rank
14th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- New Caledonia
- Saint Helena
How they compare
New Caledonia currently reports 2.3% against 2.0% in Saint Helena, a difference of 0.3%.
That makes New Caledonia's figure about 1.1 times Saint Helena's.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Saint Helena ahead.
New Caledonia ranks 12th and Saint Helena ranks 14th of 246 countries.
Saint Helena has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | New Caledonia | Saint Helena | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.9% | 2.7% | 0.9% | Saint Helena |
| 2020s | 2.2% | 2.3% | 0.1% | Saint Helena |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, New Caledonia or Saint Helena?
- New Caledonia, at 2.3% against 2.0% in Saint Helena as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between New Caledonia and Saint Helena?
- 0.3%, with New Caledonia ahead.
- How many years of comparable data are there for New Caledonia and Saint Helena?
- 10 years are reported by both, from 2015 to 2024.
- How do New Caledonia and Saint Helena rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- New Caledonia ranks 12th and Saint Helena ranks 14th of 246 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.